Pathology
Illuminated
With the HALO® Image Analysis Platform, the gold standard analysis solution for digital pathology




Explore Our Solutions
Backed by cutting edge technology, an uncompromising focus on ease-of-use and dedicated customer service, Indica Labs’ software and services are being used to make vital discoveries in pathology labs and research organizations around the world. Discover how our solutions can help you.
HALO® Image Analysis
With uncompromising ease-of-use and flexibility, the HALO® Image Analysis Platform can adapt to any image analysis application.
HALO AI Deep Learning
HALO AI, the first of its kind intuitive interface for deep learning in digital pathology, is putting the power of AI in the hands of the pathologist.
HALO Link Image Management
Share images and analysis data with remote collaborators using HALO Link, our browser-based image management system.
Pharma Services
If you are overwhelmed with your image analysis workload or need help with more complex analysis, our Pharma Services team can help.
HALO AP Clinical Workflow
The HALO AP® platform brings case-centric automation, collaboration and quantification to your Anatomic Pathology lab.
Explore Our Integrated Platforms
Click play to learn how all of our HALO products fit together to offer an end-to-end Digital Pathology workflow from bench to bedside!
Read What Our Customers Are Publishing
Our customers are making vital discoveries in oncology, neuroscience, infectious disease, and diabetes research. Check out some of the research our customers are publishing using the HALO Image Analysis Platform and Indica analysis modules.
Check out some of the research our customers are publishing using the HALO Image Analysis Platform and Indica analysis modules.
SARS-CoV-2, the causative agent of COVID-19, has been the focus of intense research since its detection in late 2019. It is known that viral infection affects several cellular processes, including senescence and inflammation, and prior studies also point toward SARS-CoV-2...
Learn MoreSchwannomas are sporadic, usually benign tumors that develop predominately on spinal nerve roots and cranial nerves. Inactivation of NF2 in Schwann cells (SC) is the cause of nearly all schwannomas and mutations in additional genes are few if present at...
Learn More
High Impact Publications with the HALO® Image Analysis Platform
Browse this selection of high-impact publications to learn how HALO image analysis is leveraged in fields from immuno-oncology to neuroscience and infectious disease.
Submit the form below to view the requested document

RNAscope® Publications with the HALO® Image Analysis Platform
Read this publications list to see examples of research in areas from neuroscience to oncology using HALO to analyze RNAscope images.
Submit the form below to view the requested document
Check out some of the research our customers are publishing using the HALO AI Deep Learning Classifier Add-on.
Predictive biomarkers to determine which non small cell lung cancer (NSCLC) patients will respond to immunotherapy are currently lacking. In this Nature Cancer publication, the authors combine computed tomography imaging, PD-L1 immunohistochemistry (IHC), and genomic data to predict responses to...
Learn MoreThis study examined CD8+ cell distribution in hepatocellular carcinoma (HCC) and peritumoral liver tissue to investigate the overall survival (OS) and recurrence-free survival (RFS). It is well understood that CD8+ lymphocytes are involved in both the anti-tumor response and in...
Learn More
HALO AI High Impact Publications
Review this selection of high-impact publications for examples of HALO AI applications in fields ranging from metabolism to immuno-oncology and myology.
Submit the form below to view the requested document
Check out some of the research our customers are publishing using the HALO Link Image Management Platform.
Melanoma, a highly aggressive type of skin cancer originating from pigment-producing cells called melanocytes, can be a source of diagnostic confusion for pathologists. While primary melanomas are easily recognizable, metastatic melanomas can dedifferentiate and exhibit varied and misleading cyto-architectural characteristics,...
Learn MoreHigh-grade serous ovarian cancer (HGSC) is known to have a high degree of both genetic and immunologic heterogeneity, can be resistant to chemotherapy, and commonly recurs in patients. It is also the most common form of ovarian cancer and represents...
Learn MoreCustomer Reviews
Read independent SelectScience reviews on HALO® and learn how these customers are using Indica Labs’ solutions to streamline their workflows.

HALO is the simply the best whole-slide analysis software available.
"HALO is simply the best whole-slide analysis software available. We have a large core facility, scanning over 15,000 brightfield and 2,000 fluorescence slides per year (plus many confocal microscopes, etc.). For whole-slide analysis, we formerly used Genie (from Aperio), and InForm (from Perkin Elmer), and we have collaborators using Definiens (no longer available) and Visiopharm. But now we have over 50 users per month working on HALO and the other platforms have been virtually shut down. HALO is very easy to get up and running - within a 2 hour session we can get a new user started with their own classification and cell counting application. Most users run a batch analysis overnight and collect and review their results in the morning. The team at Indica Labs are quick to respond when we have a challenging analysis project - they will WebEx in and help optimize the parameters. They have the experience (and courage) to tell us if the staining is just not suitable or a more complex classifier is required."
James Jonkman
University Health Network, Advanced Optical Microscopy Facility
Excellent tool, fast, user friendly, powerful.
"I am almost completely satisfied with the HALO image analysis platform. The main areas of improvement would be in cell segmentation using membrane markers and in data analysis after datafication of the slide. My principle bottleneck is in creating actionable insight from the multiple reported parameters. I think that Indica's experience with AI and multiplex data generation positions you well to exploit the current need in the marketplace. One more thing - phenotyping manually by thresholding with no morphology/cell size, neighbor information is good but if I had a magic wand, then phenotyping would be a full suite of tools with spatial, multimarker, and morphological features that could be weighted from 0 to 1 in a machine learning classifier model."
Michael Surace
AstraZeneca
For the Pathologist, HALO is by far the best digital image analysis platform available.
"As a Pathologist specializing in digital image analysis, I have had the opportunity to use several different digital image analysis platforms. Indica Labs' HALO is by far the most accurate, versatile and user friendly digital image analysis platform that I have used. Literally within 10-15 minutes of "tuning" one of their "out of the box" detection algorithms, I can perform image analysis for most simple immunohistochemical markers. The workflow is simple, with sacanned images being imported directly into HALO with or without annotations for analysis. This even allows for remote use when working off site. The customer support is AMAZING and I routinely get same day or next day help from the technical support reps. HALO is a must have for any pathologist or scientist involved in quantifying immunohistochemical stains. In addition the HALO AI module is extremely easy to use. Within 20 minutes I was able to set up AI detection of tumor vs. normal tissue, as well as tumor epithelium vs. stroma. HALO provides everything one needs for quantification of IHC for clinical and pre-clinical studies (of course with supervision of a pathologist). Best of all: it is fun, like a video game for Pathologists! "
Philip Martin
AstraZeneca
We use HALO & HALO-Link daily to coordinate studies for our analysts and pathologists.
"HALO is a whole-slide image analysis platform that is designed to work how pathologists classify & score images using a microscope. It uses a set of tools that are very familiar to anyone who has used any type of image viewing/editing program at home. It can be learned in a day to analyze brightfield & fluorescent whole slide images and TMAs. There are sophisticated tools to analyze tissues labeled by chromogenic and fluorescent IHC, RNAScope, FISH & ISH. HALO may be installed on stand-alone workstations or cloud services such as AWS. File sharing through HALO-Link lets user access studies through a simple web-interface sharing a common database. HALO AI allows any user to developing sophisticated AI based tissue classification without the need for external programs or expensive computing hardware."
Timothy Baradet
Bristol-Myers Squibb
Amazing software and service.
"Indica labs is of great support when using HALO. Their customer service is really great. HALO is a very user friendly software, but the technical support is also what makes it the best digital pathology software on the market. they are always open to any suggestion and the response time is usually very short."
Camille Britton-Rivet
Immunocore
Highly recommend.
"I work mostly with multiplex immunohistochemistry images evaluating the tumor microenvironment with a focus on tumor infiltration and cell-cell interactions. I've used several image analysis softwares over the years, but I continue to use HALO because it is easy to use yet very powerful. I started using HALO back when Indica Labs was a much smaller company and before they launched HALO Link (which I also like). Although they've grown substantially, they continue to try to provide great customer service and are always working to improve their product. No technology is perfect, but they appear to be passionate about getting past the hurdles of image analysis and to expand the functionality of the software while keeping the learning curve reasonable. I put 4/5 for Ease of Use due more to some functionality improvements that are needed."
Kimberly Smythe
Fred Hutch Cancer Center
Latest News
Catch up on the latest blogs, press releases, publications, and other news at Indica Labs.

Merge by Merative Partners with Indica Labs to Bring Digital Pathology into Enterprise Imaging Solutions
Ann Arbor, MI and Albuquerque, NM – 27 November, 2023 – Merge by Merative, an industry leader in medical imaging solutions, signed an agreement with Indica Labs, a leading provider of AI-powered digital pathology solutions. This partnership will enable healthcare

Press Release: Indica Labs Is Named a Top Workplace by the Albuquerque Journal for the Fourth Year Running
Albuquerque, NM, 26 June, 2023 – Indica Labs, a leading provider of computational pathology software, is delighted to announce that they have been awarded a Top Workplaces™ honor by The Albuquerque Journal for the fourth year in a row.

Indica Labs Launches Comprehensive Management Service for HALO® Software in AWS Cloud-Hosted Environments
Albuquerque, NM – 8 June 2023 – Indica Labs today announces the launch of a service offering deployment and on-going support of its HALO® digital pathology software in a fully managed cloud-hosted environment powered by Amazon Web Services (AWS).

Indica Labs and Lunit Announce a Strategic Alliance for Seamless Integrated Digital Pathology AI Workflows
Albuquerque, NM and Seoul, South Korea – 25 April 2023 – Indica Labs, an industry leader in quantitative digital pathology and image management innovations, and Lunit, a leading medical AI software platform company focused on cancer biomarkers announced an agreement
Melanoma, a highly aggressive type of skin cancer originating from pigment-producing cells called melanocytes, can be a source of diagnostic confusion for pathologists. While primary melanomas are easily recognizable, metastatic melanomas can dedifferentiate and exhibit varied and misleading cyto-architectural characteristics,...
Learn MoreHigh-grade serous ovarian cancer (HGSC) is known to have a high degree of both genetic and immunologic heterogeneity, can be resistant to chemotherapy, and commonly recurs in patients. It is also the most common form of ovarian cancer and represents...
Learn More
HALO AP® 2.2 Features and Functionalities
In this blog post, we’ll delve into the exciting new features and quality-of-life improvements in the latest release of HALO AP®, a CE marked, AI powered and pathologist driven enterprise digital pathology platform from Indica Labs. We will also provide information about when you can expect your chance to upgrade

An interview with Jonathon Bartlett, Chief Human Resources Officer – Indica Labs
An interview with Jonathon Bartlett, Chief Human Resources Officer – Indica Labs

Taking HALO® to the Cloud with Indica Labs Cloud Services
In this blog post we will discuss the basics of cloud computing, benefits and considerations of cloud vs. traditional deployments, and how our Professional Services team can help you optimize your cloud deployment.

Finding the Right Expertise and Tools with Indica Labs’ Pharma Services
Indica Labs’ Pharma Services is a growing team of experienced image analysts and imaging scientists with backgrounds in digital pathology, immuno-oncology, cancer biology, neuroscience, bioinformatics, and data science.
Webinars and Events
Check out our upcoming and most popular webinars and events!

Indica Labs’ London HALO® User Group Meeting
6 December 2023 | Indica Labs is pleased to announce our London HALO® User Group Meeting to be held in London on 6 December 2023 at the InterContinental London (the O2) from 12:00 – 16:00.

Lung PD-L1 AI: Development and Validation of an Automated PD-L1 Tumor Proportion Scoring Algorithm in Non-Small Cell Lung Cancer
30 November 2023 | Learn how to implement Lung PD-L1 AI to assist PD-L1 scoring in non-small cell lung cancer

Masterclass Webinar: Intro to the HALO AI Toolbox
29 June 2023 | Join us for this 1-hour webinar to see a breakdown of the networks that make up HALO AI and applications suitable for each one.

Choosing The Right Foundation: Selecting And Deploying An Image Management System For Diagnostic Digital Pathology
18 May 2023 | In this 60-minute webinar, we will discuss considerations when selecting a digital pathology image management system for clinical diagnostics. In the first half of the event, we pose questions and suggest approaches that your group may adopt when evaluating diagnostic digital pathology platforms. A comprehensive Vendor

Transforming Pathology at Nottingham University Hospitals: Implementing Digital Pathology using HALO AP®
2 March 2023 | Learn about transformational change in how pathology services are delivered at Nottingham University Hospitals

Towards Open Pathology: Facilitating Development of Novel AI-based Tools for Digital Pathology through Collaboration and Integration
16 October 2022 | In this 1-hour workshop, Eric Runde, Chief Operating Officer at Indica Labs, will introduce Indica’s platforms, our collaborative approach to incorporating artificial intelligence (AI) into life science and clinical workflows, and the open pathology tools available to developers and industry partners. Dr. Peter Caie, Principal Scientist

HALO Prostate AI – A Tool for Automated Detection and Gleason Grading of Prostate Cancer
05 October 2022 | Join us for this 1-hour webinar to learn how to implement the HALO Prostate AI tool for prostate cancer detection and grading

Quantitative Digital Pathology: An Overview of the HALO® Image Analysis Platform
6 October 2022 | Join us for this 1-hour webinar to see a live demonstration of the HALO® image analysis platform, the gold standard analysis platform for quantitative tissue analysis in digital pathology.